KLEMP WALTER V (CEO and President) exercised options at MOLECULIN BIOTECH, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 11/6/2025ACC: 0001437749-25-033683
DirectorOfficer· CEO and President
Since Jul 2019
-7K
Net shares
Net seller
$3.5K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
28.75K acquired · 35.75K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+28.75K
Price / share
—
Trade value
—
% of position
3.9%
11/4/2025
743.61K→772.36K
Common Stock
Direct
Shares
−7K
Price / share
$0.50
Trade value
$3.48K
% of position
0.9%
11/4/2025
772.36K→765.36K
Total
Net shares
+21.75K
Net value
-$3.48K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/4/2025 | M · Option Exercise | +28.75K | — | — | 3.9% | 743.61K | 772.36K |
| Common Stock Direct | 11/4/2025 | F · Tax Withholding | −7K | $0.50 | $3.48K | 0.9% | 772.36K | 765.36K |
| Total | +21.75K | -$3.48K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
28.75K shares
Shares
−28.75K
Strike price
Held after
2.38M
Exercisable
—
11/4/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock28.75K shares | 11/4/2025 | M · Option Exercise | −28.75K | — | 2.38M |